Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
Blue curve MMWR spacer

The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.

Notice to Readers Ansamycin LM427

Since October 1983, CDC's Division of Tuberculosis Control, Center for Prevention Services, has supplied the experimental drug, ansamycin LM427, under a "compassionate" investigational new drug permit to physicians treating patients with serious mycobacterial disease unresponsive to conventional therapy. Beginning Monday, February 18, 1985, physicians requesting the drug for new patients should contact the CDC Drug Service at (404) 329-3670 during normal working hours. Ansamycin LM427 is not released at night or during weekends. The Division of Tuberculosis Control ((404) 329-2530) will continue to provide medical consultation on the treatment of mycobacterial diseases.

Disclaimer   All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to

Page converted: 08/05/98


Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A


Department of Health
and Human Services

This page last reviewed 5/2/01